The Aftermath: The Future of the Life Sciences Industries Beyond the Global RecessionJoin Deloitte at BIO2010 |
Conference: Breakout Sessions
Track: Global Biotechnology Issues
Date: Wednesday May 5, 2010
Time: 4:00 PM - 5:30 PM
Location: McCormick Place, Chicago
Room: S403B
Description
Life sciences executives are struggling to understand what the lasting effects of the global financial and economic crisis will be on the industry's business priorities and strategies. How has the restructuring of the industry been impacted by economic upheaval and are changes in direction over the last year or so temporary or permanent? Have companies’ strategies been permanently affected by the global economic recession and are they likely to behave differently as recovery occurs?
The session will:
- Explore the impact of the current global economic crisis on the life sciences segments
- Examine issues such as how the restructuring of the industry has been impacted by economic upheaval, whether changes in direction over the last year are temporary, and whether business strategies and priorities will be permanently affected by the current economic climate
- Contrast panelists’ views with the results with the 300+ responses to a life sciences executive survey on these topics
Panelists
- Nigel Holloway, Moderator, Director of Research, The Economist
- Pete Mooney, Global LSHC Consulting Leader, Deloitte Consulting LLP
- Barbara Mittelman, MD, Director, NIH Program on Public-Private Partnerships, NIH
- Dan Zabrowski, Global head of Pharmaceuticals Partnering, Roche
Last updated
